Latest meningitis Stories
Massachusetts health regulators are continuing to crack down on compounding pharmacies in the wake of the deadliest meningitis outbreak due to contaminated steroidal injections in US history.
New details have emerged over the US Food and Drug Administration’s (FDA) ineffective efforts to regulate a Massachusetts drug maker that has been the center of the national meningitis health crisis this year.
As cases of fungal meningitis stemming from tainted steroid injections continue to climb, lawmakers outline the scope of the deadly outbreak that has so far affected more than 438 people and has resulted in 32 deaths.
A new article being published early online in Annals of Internal Medicine describes the diagnosis and treatment protocol established in a Roanoke, Va. hospital to care for dozens of patients presenting with suspected fungal meningitis related to contaminated epidural spinal injections.
People recovering from dangerous fungal meningitis have a new worry now, after several people treated for the deadly infection have gone home to recover only to return to the ER with a second illness, according to health experts.
Ameridose, a sister company to the US compounding facility responsible for a fungal meningitis outbreak that has now killed 28 people in 19 states, announced Wednesday it is invoking a voluntary recall of its products in cooperation with regulators.
Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...
- A volcanic mudflow.